Table 1.
The main characteristics of patients at baseline
| Intervention group | Control group | ||
|---|---|---|---|
| n (%) | n (%) | pe | |
| Number of patients | 242 | 205 | |
| Female / Male | 148 (61.2) / 94 (38.8) | 111 (54.1) / 94 (45.9) | 0.135 |
| Outpatient / Inpatient | 189 (78.1) / 53 (21.9) | 156 (76.1) / 49 (23.9) | 0.615 |
| Register basedf clinical diagnosis (ICD-10): | |||
| Primary psychiatric diagnosis | 0.103 | ||
| Depressive disorder (F32.x) | 98 (40.5) | 89 (50.0) | |
| Recurrent depressive disorder (F33.x) | 92 (38.0) | 48 (27.0) | |
| Bipolar disorder (F31.x) | 19 (7.9) | 17 (9.6) | |
| Anxiety disorders (F40–43.x) | 9 (3.7) | 20 (9.6) | |
| Other disorders | 18 (7.4) | – | |
| Secondary psychiatric diagnosis | |||
| Panic disorder (F41.x) | 26 (10.7) | 16 (7.8) | 0.296 |
| Phobic and other anxiety disorders (F40,42,43.x) | 22 (9.1) | 22 (10.8) | 0.550 |
| Personality disorder (F6x.x) | 9 (3.7) | 17 (8.4) | 0.037 |
| Tertiary psychiatric diagnosis | |||
| Anxiety disorder (F4x.x) | 12 (5.0) | 5 (2.5) | 0.168 |
| Personality disorder (F6x.x) | 8 (3.3) | 10 (4.9) | 0.393 |
| Alcohol dependence (current) | 47 (19.4) | n/a | |
| Use of other substance (last 12 months) | 22 (9.1) | n/a | |
| mean (SD) | mean (SD) | p | |
| Age (years) | 38.8 (12.2) | 39.5 (12.7) | 0.567 |
| Baseline MADRSa | 23.2 (6.7) | n/a | |
| Baseline BDIb | 27.9 (7.3) | 28.8 (7.9) | 0.214 |
| Baseline AUDITc | 10.7 (9.9) | 9.8 (9.0) | 0.319 |
| Baseline GAFd | 45.9 (10.7) | 43.6 (11.7) | 0.035 |
aMontgomery–Åsberg Depression Rating Scale
bBeck Depression Inventory
cAlcohol Use Disorders Identification Test
dGlobal Assessment of Functioning scale
ebetween groups (chi-square test)
fRegister based diagnoses determined by the responsible doctor in previous treatment contacts